查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1455239

2024 年基因型鑒定檢測全球市場報告

Genotyping Assay Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

基因型鑒定檢測市場規模預計在未來幾年將快速成長。預計到 2028 年將以 23.0% 的複合年成長率 (CAGR) 成長至 777.7 億美元。預測期內的預期成長歸因於客製化和個人化趨勢、對健康和保健的關注、電子商務的成長、智慧和功能性玻璃器皿的普及以及烹飪和調酒術趨勢的影響。預測期內預計的主要趨勢包括材料創新、創新形狀和設計的引入、智慧玻璃產品的開發、為特定飲料創建專用玻璃產品以及融入健康和安全功能。

遺傳疾病的日益普及預計將推動基因型鑒定檢測市場的成長。遺傳性疾病是由個體 DNA 異常或突變引起的。基因型鑒定測定在這些遺傳變異的識別和分析中發揮重要作用，可以檢測與特定遺傳疾病相關的特定突變和變異。例如，英國慈善機構 Gene People 在 2023 年 6 月透露，英國大約每25 名兒童中就有1 名患有遺傳性疾病，每年約有3 萬名新生兒和幼兒受到影響，另有240 萬人受到影響。超過1,000 名兒童和成人據報道已受到影響。因此，遺傳病患疾病率的增加是促進基因型鑒定檢測市場擴大的關鍵因素。

對個人化醫療的需求不斷成長也是基因型鑒定檢測市場成長的另一個關鍵驅動力。個人化醫療涉及根據個人獨特的基因組成客製化治療方案，以提供更精確、更有效的醫療保健干預措施。基因型鑒定測定在個人化醫療中至關重要，可分析個體的基因譜並實現定製藥物選擇和劑量。 2023 年 1 月，食品藥物管理局(FDA) 宣布，在 2022 年核准的35 種治療性新型分子實體(NME) 中，約34%（其中12 種）將由個人化醫療聯盟(PMC) 進行個人化治療。它被歸類為醫療。這凸顯了對個人化醫療日益成長的需求，從而推動了基因型鑒定檢測市場的成長。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球基因型鑒定檢測市場的促進因素與限制因素
    • 市場驅動力
    • 市場限制
  • 2018-2023 年全球基因型鑒定檢測市場規模、表現與成長
  • 全球基因型鑒定檢測市場規模與成長預測，2023-2028、2033

第6章市場區隔

  • 全球基因型鑒定檢測市場，依產品及服務細分、績效與預測，2018-2023、2023-2028、2033
  • 試劑和套件
  • 基因型鑒定服務
  • 裝置
  • 生物資訊學
  • 全球基因型鑒定檢測市場，依技術細分，實際與預測，2018-2023、2023-2028、2033
  • 微陣列
  • 聚合酵素鏈鎖反應
  • 順序
  • 毛細管電泳
  • 基質輔助雷射解吸或電離飛行時間質譜法
  • 其他技術
  • 全球基因型鑒定檢測市場，依最終用戶細分，實際與預測，2018-2023、2023-2028、2033
  • 藥物基因組學
  • 個性化醫療和診斷
  • 動物遺傳學
  • 農業生物技術
  • 研究和診斷實驗室
  • 學術機構

第 7 章 區域與國家分析

  • 全球基因型鑒定檢測市場，依地區、績效及預測，2018-2023、2023-2028、2033
  • 全球基因型鑒定檢測市場，依國家、表現及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 基因型鑒定檢測市場競爭格局
  • 基因型鑒定檢測市場公司概況
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific
    • Danaher Corporation
    • Eurofins Scientific SE
    • Agilent Technologies Inc.

第31章 其他重大及創新企業

  • PerkinElmer Inc.
  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • BGI Genomics
  • LGC Biosearch Technologies
  • GenScript Biotech
  • Inotiv Inc.
  • Promega Corporation
  • Luminex Corporation
  • Integrated DNA Technologies Inc.
  • Integrated DNA Technologies Ltd.
  • Sequenom Inc.
  • 23andMe Inc.
  • Novogene Corporation

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r16240

A genotyping assay is a laboratory technique or method employed to determine an individual's genetic makeup at specific genetic loci or positions within their DNA. It involves the identification and analysis of genetic variations, such as single nucleotide polymorphisms (SNPs) or insertions and deletions, present in an individual's genome.

The primary products and services in the genotyping assay market include reagents and kits, genotyping services, instruments, and bioinformatics. Reagents and kits serve as crucial components in various scientific and laboratory processes, especially in fields such as molecular biology, chemistry, and diagnostics. Various technologies are employed in genotyping assays, including microarrays, polymerase chain reaction, sequencing, capillary electrophoresis, matrix-assisted laser desorption or ionization-time of flight mass spectrometry, and others. These technologies cater to diverse end-users such as pharmacogenomics, personalized medicine and diagnostics, animal genetics, agricultural biotechnology, research and diagnostic laboratories, and academic institutes.

The genotyping assay market research report is one of a series of new reports from The Business Research Company that provides genotyping assay market statistics, including genotyping assay industry global market size, regional shares, competitors with a genotyping assay market share, detailed genotyping assay market segments, market trends and opportunities, and any further data you may need to thrive in the genotyping assay industry. This genotyping assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genotyping assay market size has grown exponentially in recent years. It will grow from $27.7 billion in 2023 to $33.98 billion in 2024 at a compound annual growth rate (CAGR) of 22.7%. The growth observed in the historical period can be attributed to the traditional usage of glassware, cultural and lifestyle influences, economic factors, the growth of the hospitality and foodservice industry, and trends in gifts and decor.

The genotyping assay market size is expected to see exponential growth in the next few years. It will grow to $77.77 billion in 2028 at a compound annual growth rate (CAGR) of 23.0%. The anticipated growth in the forecast period can be attributed to the trends of customization and personalization, the focus on health and wellness, the growth of e-commerce, the popularity of smart and functional glassware, and the influence of culinary and mixology trends. Major trends expected in the forecast period include material innovation, the introduction of innovative shapes and designs, the development of smart glassware, the creation of specialized glassware for specific beverages, and the incorporation of health and safety features.

The increasing prevalence of genetic disorders is expected to drive the growth of the genotyping assay market. Genetic disorders result from abnormalities or mutations in an individual's DNA. Genotyping assays play a crucial role in identifying and analyzing these genetic variations, enabling the detection of specific mutations or variations associated with particular genetic disorders. For example, Gene People, a UK-based charity organization, reported in June 2023 that approximately one in every 25 children in the UK had a genetic disorder, affecting around 30,000 newborns and young children annually, along with more than 2.4 million children and adults. Hence, the growing prevalence of genetic disorders is a significant factor contributing to the expansion of the genotyping assay market.

The rising demand for personalized medicine is another key driver for the growth of the genotyping assay market. Personalized medicine involves tailoring medical treatment to an individual's unique genetic makeup, offering more precise and effective healthcare interventions. Genotyping assays are essential in personalized medicine to analyze an individual's genetic profile, enabling customized drug selection and dosage. In January 2023, the Food and Drug Administration (FDA) reported that out of the 35 therapeutic new molecular entities (NMEs) approved in 2022, approximately 34% (12 of them) were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This highlights the increasing demand for personalized medicine, which, in turn, is propelling the growth of the genotyping assay market.

The growth of the genotyping assay market faces a significant challenge due to the high cost of equipment, which pertains to specialized devices used in genetic analysis to determine an individual's genotype. This cost obstacle hinders market expansion by limiting smaller laboratories' access, creating budgetary constraints, reducing adoption rates, diverting resources, influencing ROI considerations, facing competitive pressures, and establishing barriers to market entry. For example, Illumina, Inc., a US-based biotechnology company, states that basic PCR machines can start at $5,000, while advanced RT-PCR or qPCR systems range from $15,000 to over $90,000. Moreover, the latest DNA sequencing machines have a base machine priced at $985,000, with a more advanced version available for $1.25 million, thereby restraining the genotyping assay market's growth.

Key players in the genotyping assay market are actively advancing genomic research, such as the development of CE-IVD marked assays to detect treatment-resistant strains of HIV-1. An example is the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit by Thermo Fisher Scientific, launched in January 2023. This Sanger sequencing-based assay examines HIV-positive samples to identify genetic variants resistant to common antiretroviral therapeutics. The kit's unique features include assessing genomic mutations, utilizing HIV RNA, detecting drug resistance mutations through gold-standard Sanger sequencing technology, and being designed for clinical use. This product launch adds value by enhancing the detection of treatment-resistant HIV-1 strains, providing ready-to-use reagents and controls, meeting regulatory requirements, exhibiting high-performance characteristics, and being compatible with existing sequencing platforms and workflows.

In August 2023, Transnetyx Inc., a US-based biotechnology company, acquired Laragen Inc. for an undisclosed sum. Through this acquisition, Transnetyx aims to broaden its solutions by incorporating sequencing and next-generation sequencing (NGS) services, offering large research institutes improved access to cutting-edge genetic services. Laragen Inc., also based in the US, specializes in providing sequencing and genotyping assay services for DNA.

Major companies operating in the genotyping assay market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv Inc., Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., Integrated DNA Technologies Ltd., Sequenom Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies PLC, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs, TrimGen Corporation, Xcelris Genomics

North America was the largest region in the genotyping assay market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genotyping assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genotyping assay market includes revenues earned by entities that provide genotyping assay services such as single nucleotide polymorphisms (SNPs) genotyping, short tandem repeats (STRs) genotyping, whole genome genotyping, and clinical genotyping services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genotyping assay market consists of sales of products such as polymerase chain reaction (PCR) primers, SNP genotyping kits, DNA extraction kits, and microarray chips. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genotyping Assay Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genotyping assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genotyping assay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genotyping assay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product And Service: Reagents And Kits; Genotyping Services; Instruments; Bioinformatics
  • 2) By Technology: Microarrays; Polymerase Chain Reaction; Sequencing; Capillary Electrophoresis; Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry; Other Technologies
  • 3) By End-User: Pharmacogenomics; Personalized Medicine And Diagnostics; Animal Genetics; Agricultural Biotechnology; Research And Diagnostic Laboratories; Academic Institutes
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific; Danaher Corporation; Eurofins Scientific SE; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genotyping Assay Market Characteristics

3. Genotyping Assay Market Trends And Strategies

4. Genotyping Assay Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Genotyping Assay Market Size and Growth

  • 5.1. Global Genotyping Assay Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Genotyping Assay Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Genotyping Assay Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Genotyping Assay Market Segmentation

  • 6.1. Global Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Reagents And Kits
  • Genotyping Services
  • Instruments
  • Bioinformatics
  • 6.2. Global Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Microarrays
  • Polymerase Chain Reaction
  • Sequencing
  • Capillary Electrophoresis
  • Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry
  • Other Technologies
  • 6.3. Global Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmacogenomics
  • Personalized Medicine And Diagnostics
  • Animal Genetics
  • Agricultural Biotechnology
  • Research And Diagnostic Laboratories
  • Academic Institutes

7. Genotyping Assay Market Regional And Country Analysis

  • 7.1. Global Genotyping Assay Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Genotyping Assay Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Genotyping Assay Market

  • 8.1. Asia-Pacific Genotyping Assay Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Genotyping Assay Market

  • 9.1. China Genotyping Assay Market Overview
  • 9.2. China Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Genotyping Assay Market

  • 10.1. India Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Genotyping Assay Market

  • 11.1. Japan Genotyping Assay Market Overview
  • 11.2. Japan Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Genotyping Assay Market

  • 12.1. Australia Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Genotyping Assay Market

  • 13.1. Indonesia Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Genotyping Assay Market

  • 14.1. South Korea Genotyping Assay Market Overview
  • 14.2. South Korea Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Genotyping Assay Market

  • 15.1. Western Europe Genotyping Assay Market Overview
  • 15.2. Western Europe Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Genotyping Assay Market

  • 16.1. UK Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Genotyping Assay Market

  • 17.1. Germany Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Genotyping Assay Market

  • 18.1. France Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Genotyping Assay Market

  • 19.1. Italy Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Genotyping Assay Market

  • 20.1. Spain Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Genotyping Assay Market

  • 21.1. Eastern Europe Genotyping Assay Market Overview
  • 21.2. Eastern Europe Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Genotyping Assay Market

  • 22.1. Russia Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Genotyping Assay Market

  • 23.1. North America Genotyping Assay Market Overview
  • 23.2. North America Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Genotyping Assay Market

  • 24.1. USA Genotyping Assay Market Overview
  • 24.2. USA Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Genotyping Assay Market

  • 25.1. Canada Genotyping Assay Market Overview
  • 25.2. Canada Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Genotyping Assay Market

  • 26.1. South America Genotyping Assay Market Overview
  • 26.2. South America Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Genotyping Assay Market

  • 27.1. Brazil Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Genotyping Assay Market

  • 28.1. Middle East Genotyping Assay Market Overview
  • 28.2. Middle East Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Genotyping Assay Market

  • 29.1. Africa Genotyping Assay Market Overview
  • 29.2. Africa Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Genotyping Assay Market Competitive Landscape And Company Profiles

  • 30.1. Genotyping Assay Market Competitive Landscape
  • 30.2. Genotyping Assay Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Danaher Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Eurofins Scientific SE
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Agilent Technologies Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Genotyping Assay Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. Illumina Inc.
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Qiagen NV
  • 31.5. BGI Genomics
  • 31.6. LGC Biosearch Technologies
  • 31.7. GenScript Biotech
  • 31.8. Inotiv Inc.
  • 31.9. Promega Corporation
  • 31.10. Luminex Corporation
  • 31.11. Integrated DNA Technologies Inc.
  • 31.12. Integrated DNA Technologies Ltd.
  • 31.13. Sequenom Inc.
  • 31.14. 23andMe Inc.
  • 31.15. Novogene Corporation

32. Global Genotyping Assay Market Competitive Benchmarking

33. Global Genotyping Assay Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Genotyping Assay Market

35. Genotyping Assay Market Future Outlook and Potential Analysis

  • 35.1 Genotyping Assay Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Genotyping Assay Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Genotyping Assay Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer